Evgen Pharma plc (LON:EVG - Get Free Report) insider Toni Hänninen bought 1,000,000 shares of the firm's stock in a transaction dated Friday, April 5th. The shares were acquired at an average price of GBX 1 ($0.01) per share, for a total transaction of £10,000 ($12,553.35).
Evgen Pharma Price Performance
Shares of LON:EVG opened at GBX 0.80 ($0.01) on Friday. Evgen Pharma plc has a 1 year low of GBX 0.75 ($0.01) and a 1 year high of GBX 4.05 ($0.05). The firm has a market capitalization of £2.20 million, a price-to-earnings ratio of -80.00 and a beta of 1.47. The business's 50 day moving average price is GBX 1.09 and its 200-day moving average price is GBX 1.53.
Evgen Pharma Company Profile
(
Get Free Report)
Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
